These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28935113)

  • 1. Directed Evolution of Glycopeptides Using mRNA Display.
    Horiya S; Bailey JK; Krauss IJ
    Methods Enzymol; 2017; 597():83-141. PubMed ID: 28935113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed evolution of multivalent glycopeptides tightly recognized by HIV antibody 2G12.
    Horiya S; Bailey JK; Temme JS; Guillen Schlippe YV; Krauss IJ
    J Am Chem Soc; 2014 Apr; 136(14):5407-15. PubMed ID: 24645849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization.
    Gray ES; Moore PL; Pantophlet RA; Morris L
    J Virol; 2007 Oct; 81(19):10769-76. PubMed ID: 17634239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
    Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
    J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake.
    Sun L; Ishihara M; Middleton DR; Tiemeyer M; Avci FY
    J Biol Chem; 2018 Sep; 293(39):15178-15194. PubMed ID: 30115684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc.
    Yang Q; Li C; Wei Y; Huang W; Wang LX
    Bioconjug Chem; 2010 May; 21(5):875-83. PubMed ID: 20369886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
    Ingale J; Tran K; Kong L; Dey B; McKee K; Schief W; Kwong PD; Mascola JR; Wyatt RT
    J Virol; 2014 Dec; 88(24):14002-16. PubMed ID: 25253346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
    Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
    Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.
    Luallen RJ; Fu H; Agrawal-Gamse C; Mboudjeka I; Huang W; Lee FH; Wang LX; Doms RW; Geng Y
    J Virol; 2009 May; 83(10):4861-70. PubMed ID: 19264785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.
    Coss KP; Vasiljevic S; Pritchard LK; Krumm SA; Glaze M; Madzorera S; Moore PL; Crispin M; Doores KJ
    J Virol; 2016 Dec; 90(24):11132-11144. PubMed ID: 27707925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120.
    Doran RC; Morales JF; To B; Morin TJ; Theolis R; O'Rourke SM; Yu B; Mesa KA; Berman PW
    Mol Immunol; 2014 Nov; 62(1):219-226. PubMed ID: 25016576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
    Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
    J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoform analysis of recombinant and human immunodeficiency virus envelope protein gp120 via higher energy collisional dissociation and spectral-aligning strategy.
    Yang W; Shah P; Toghi Eshghi S; Yang S; Sun S; Ao M; Rubin A; Jackson JB; Zhang H
    Anal Chem; 2014 Jul; 86(14):6959-67. PubMed ID: 24941220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
    Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
    J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding.
    Panico M; Bouché L; Binet D; O'Connor MJ; Rahman D; Pang PC; Canis K; North SJ; Desrosiers RC; Chertova E; Keele BF; Bess JW; Lifson JD; Haslam SM; Dell A; Morris HR
    Sci Rep; 2016 Sep; 6():32956. PubMed ID: 27604319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoenzymatic Synthesis and Antibody Binding of HIV-1 V1/V2 Glycopeptide-Bacteriophage Q
    Zong G; Toonstra C; Yang Q; Zhang R; Wang LX
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Synthesis and Binding Study of HIV V3 Glycopeptides Reveal the Fine Epitopes of Several Broadly Neutralizing Antibodies.
    Orwenyo J; Cai H; Giddens J; Amin MN; Toonstra C; Wang LX
    ACS Chem Biol; 2017 Jun; 12(6):1566-1575. PubMed ID: 28414420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.
    Go EP; Ding H; Zhang S; Ringe RP; Nicely N; Hua D; Steinbock RT; Golabek M; Alin J; Alam SM; Cupo A; Haynes BF; Kappes JC; Moore JP; Sodroski JG; Desaire H
    J Virol; 2017 May; 91(9):. PubMed ID: 28202756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition.
    Cai H; Zhang RS; Orwenyo J; Giddens J; Yang Q; LaBranche CC; Montefiori DC; Wang LX
    J Med Chem; 2018 Nov; 61(22):10116-10125. PubMed ID: 30384610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies.
    Amin MN; McLellan JS; Huang W; Orwenyo J; Burton DR; Koff WC; Kwong PD; Wang LX
    Nat Chem Biol; 2013 Aug; 9(8):521-6. PubMed ID: 23831758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.